Literature DB >> 23883842

A case series of chronic necrotizing pulmonary aspergillosis and a new proposal.

Takayoshi Tashiro1, Koichi Izumikawa, Masato Tashiro, Yoshitomo Morinaga, Shigeki Nakamura, Yoshifumi Imamura, Taiga Miyazaki, Hiroshi Kakeya, Yoshihiro Yamamoto, Katsunori Yanagihara, Tomayoshi Hayashi, Takeshi Nagayasu, Shigeru Kohno.   

Abstract

Chronic necrotizing pulmonary aspergillosis (CNPA) is an indolent, cavitating process in the lungs resulting from invasion of lung tissue by Aspergillus spp. However, most previous reports have not found any clear evidence of parenchymal invasion, and clinical distinction between CNPA and chronic cavitary pulmonary aspergillosis (CCPA) is difficult. We performed a histopathological study of lung specimens obtained by autopsy, surgical resection, or biopsy to clarify the characteristic pathological and clinical features of CNPA. We present 4 cases of proven CNPA, diagnosed by histological demonstration of tissue invasion by the fungus, and present its clinical features. These 4 patients were male, and the mean age was 62 years (range, 51-75 years). Their underlying conditions were chronic obstructive pulmonary disease (n = 3), sequelae of pulmonary tuberculosis (n = 2), and diabetes mellitus (n = 1). Aspergillus precipitation tests were positive for 3; and Aspergillus antigen tests were positive for 2 on admission, and subsequently, for all 4. The isolated pathogens were Aspergillus niger for 1 and A. fumigatus for 1. Initial radiographic findings were infiltrates or nodular lesions, which slowly progressed and cavitated before the appearance of fungus balls. Although CNPA has characteristic pathological features, it is clinically difficult to distinguish CNPA from CCPA. We propose to use the term chronic progressive pulmonary aspergillosis for both CNPA and CCPA.

Entities:  

Mesh:

Year:  2013        PMID: 23883842     DOI: 10.7883/yoken.66.312

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  6 in total

1.  Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

Authors:  M T Hedayati; Y Azimi; A Droudinia; B Mousavi; A Khalilian; N Hedayati; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-24       Impact factor: 3.267

2.  Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.

Authors:  G Cucchetto; A Cazzadori; M Conti; G L Cascio; P Braggio; E Concia
Journal:  Infection       Date:  2014-11-29       Impact factor: 3.553

3.  Aspergillus nodules in chronic granulomatous disease attributable to Aspergillus ochraceus.

Authors:  Samihah Moazam; David W Denning
Journal:  Med Mycol Case Rep       Date:  2017-06-21

4.  A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL).

Authors:  Findra Setianingrum; Anna Rozaliyani; Robiatul Adawiyah; Ridhawati Syam; Mulyati Tugiran; Cut Yulia Indah Sari; Finny Nandipinto; Johannes Ramnath; Arief Riadi Arifin; Diah Handayani; Erlina Burhan; Martin Rumende; Retno Wahyuningsih; Riina Rautemaa-Richardson; David W Denning
Journal:  Thorax       Date:  2021-11-30       Impact factor: 9.102

5.  The scab-like sign: A CT finding indicative of haemoptysis in patients with chronic pulmonary aspergillosis?

Authors:  Haruka Sato; Fumito Okada; Shunro Matsumoto; Hiromu Mori; Junji Kashiwagi; Eiji Komatsu; Toru Maeda; Haruto Nishida; Tsutomu Daa; Satoshi Ohtani; Kenji Umeki; Masaru Ando; Junichi Kadota
Journal:  Eur Radiol       Date:  2018-05-03       Impact factor: 7.034

6.  Chronic Pulmonary Aspergillosis Situation among Post Tuberculosis Patients in Vietnam: An Observational Study.

Authors:  Ngoc Thi Bich Nguyen; Huy Le Ngoc; Nhung Viet Nguyen; Luong Van Dinh; Hung Van Nguyen; Huyen Thi Nguyen; David W Denning
Journal:  J Fungi (Basel)       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.